QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia 期刊论文 2017, 卷号: 4, 期号: 2, 页码: 75-85 作者:  Ye Dingwei;  Huang Yiran;  Zhou Fangjian;  Xie Keji;  Matveev Vsevolod 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/04 Abiraterone  Chemotherapy-naïve  Metastatic castration-resistant prostate cancer  Prednisone  Prostate specific antigen   Efficacy and safety of abiraterone acetate in asymptomatic or mildly symptomatic chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a phase III, double-blind, randomized, placebo-controlled study conducted in China, 会议论文 BJU INTERNATIONAL, 2015-08-01 作者:  Sun, Yinghao;  Ye, Dingwei;  Huang, Yiran;  Zhou, Fangjian;  Xie, Keji 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Efficacy and safety of abiraterone acetate in asymptomatic or mildly symptomatic chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a phase III, double-blind, randomized, placebo-controlled study conducted in China, 期刊论文 2015, 卷号: 116, 期号: ,SI, 页码: 2-2 作者:  Sun, Yinghao;  Ye, Dingwei;  Huang, Yiran;  Zhou, Fangjian;  Xie, Keji 收藏  |  浏览/下载：13/0  |  提交时间：2020/01/13